Jeong Heo ET AL: "Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer", Nature Medicine, vol. 19, no. 3, 10 February 2013 (2013-02-10), pages 329-336, XP055184099, ISSN: 1078-8956, DOI: 10.1038/nm.3089 (B1)

anonymous: "NCT00554372 on 2008_02_26 - A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma", ClinicalTrials.gov , 26 February 2008 (2008-02-26), pages 1-5, XP002663553, Retrieved from the Internet: URL:http://clinicaltrials.gov/archive/NCT0 0554372/2008_02_26 [retrieved on 2011-11-15] (B1)

KIM ET AL: "167. Both Oncolysis and Tumor Immunity Are Involved in an Autitumoral Efficacy by Intratumoral Injection of Recombinant Vaccinia Virus (TK Deleted, hGM-CSF Inserted Wyeth Strain) in a VX2 Rabbit Model", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 11, 15 August 2005 (2005-08-15), page 67, XP005015506, ISSN: 1525-0016 (B1)

KIM ET AL: "168. Antitumoral Efficacy of Multiple Injection of JX-594 (Thymidine Kinase (TK) Deleted, Human GM-CSF Inserted Wyeth Strain) Via Tail Vein in N-Nitrosomorpholine (NNM) Treated Rats", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 11, 15 August 2005 (2005-08-15), page 67, XP005015507, ISSN: 1525-0016 (B1)

KIM ET AL: "Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 14, no. 3, 12 August 2006 (2006-08-12), pages 361-370, XP005844829, ISSN: 1525-0016, DOI: 10.1016/J.YMTHE.2006.05.008 (B1)

LIU T-C ET AL: "Clinical trial results with oncolytic virotherapy: A century of promise, a decade of progress", NATURE CLINICAL PRACTICE ONCOLOGY, NATURE PUBLISHING GROUP, vol. 4, no. 2, 1 January 2007 (2007-01-01) , pages 101-117, XP009100877, ISSN: 1743-4254, DOI: 10.1038/NCPONC0736 (B1)

MASTRANGELO ET AL. CANCER GENE THER. vol. 6, no. 5, 1998, pages 409 - 422, XP003025629 (B1)

MCCART ET AL. CANCER RESEARCH vol. 61, 2001, pages 8751 - 8757, XP002331814 (B1)

QIN H. ET AL. HUM. GENE THER. vol. 7, 1996, pages 1853 - 1860, XP008122421 (B1)

TA-CHIANG LIU ET AL: "The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 16, no. 10, 1 January 2008 (2008-01-01), pages 1637-1642, XP008155715, ISSN: 1525-0016, DOI: 10.1038/MT.2008.143 [retrieved on 2008-07-15] (B1)

THORNE ET AL: "169. The Creation of Novel Oncolytic Vaccinia Virus Vectors for Efficient Systemic Delivery of Transgenes to Tumors", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 11, 15 August 2005 (2005-08-15), page 67, XP005015508, ISSN: 1525-0016 (B1)

THORNE STEPHEN H ET AL: "THE USE OF ONCOLYTIC VACCINIA VIRUSES IN THE TREATMENT OF CANCER: A NEW ROLE FOR AN OLD ALLY?", CURRENT GENE THERAPY, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 5, no. 4, 1 January 2005 (2005-01-01) , pages 429-443, XP008075683, ISSN: 1566-5232, DOI: 10.2174/1566523054546215 (B1)

WO-A2-2007/030668 (B1)

anonymous: "NCT00429312 on 2007_03_02 - A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma", ClinicalTrials.gov , 2 March 2007 (2007-03-02), pages 1-4, XP002663554, Retrieved from the Internet: URL:http://clinicaltrials.gov/archive/NCT0 0429312/2007_03_02 [retrieved on 2011-11-14] (B1)

KIM D H ET AL: "REPLICATING VIRUSES AS SELECTIVE CANCER THERAPEUTICS", MOLECULAR MEDICINE TODAY, ELSEVIER, CAMBRIDGE, GB, vol. 2, no. 12, 1 December 1996 (1996-12-01), pages 519-527, XP000891648, ISSN: 1357-4310, DOI: 10.1016/S1357-4310(97)81456-6 (B1)